GSK stops Keytruda combo trials after ICOS drug falls short

GSK stops Keytruda combo trials after ICOS drug falls short

Submitted by admin on April 15, 2021 - 10:37am
Source: 
Fierce Biotech
News Tags: 
GSK
feladilimab
Keytruda
clinical trials
ICOS
Headline: 
GSK stops Keytruda combo trials after ICOS drug falls short
snippet: 

GlaxoSmithKline has stopped two clinical trials of feladilimab in combination with Keytruda after an interim review. Other studies of the ICOS agonist are continuing, but the future of the program is now in doubt.

Do Not Allow Advertisers to Use My Personal information